Three Years of Daily BCI Use Reframes Brain Implants as Infrastructure, Not Experiments

7. Three Years of Daily BCI Use Reframes Brain Implants as Infrastructure, Not Experiments

Casey Harrell, a man living with ALS-related paralysis, has now logged thousands of hours communicating through a brain-computer interface over nearly three years of continuous use. First reported by MIT Technology Review, Harrell's implanted electrode array originally produced spoken sentences with research team support in 2023. By 2026, that dependency has shrunk considerably. The system has moved from supervised lab sessions to something closer to a daily communication tool, making Harrell what researchers describe as "the first power user" of speech-restoration BCI technology.

That framing matters competitively. Neuralink's N1 implant has generated significant attention since its first human trial in January 2024, but its published use cases center on cursor control and typing speed records rather than sustained, years-long speech restoration. Synchron's Stentrode has demonstrated longer-term implant safety, but communication throughput remains limited. Harrell's case, backed by a UC Davis and Meta-affiliated research team, now represents the most documented longitudinal record of a BCI functioning as a primary communication channel. That shifts the evidentiary bar. Regulators at the FDA, currently weighing expanded BCI trial approvals, now have a three-year safety and utility dataset that no commercial player has yet matched in the speech domain.

The broader pattern here is the move from proof-of-concept to durability benchmarks. Early BCI coverage fixated on first-use milestones: first cursor move, first sentence, first tweet. The field is entering a second phase where the question is not "can it work once" but "does it hold up across years of real-world load." That is the same transition cloud infrastructure went through in the early 2010s. Watch for Neuralink and Synchron to publish their own longitudinal data in response, and for FDA guidance on long-term implant criteria to tighten around exactly this kind of multi-year evidence.

Source: This man with ALS is "the first power user" of a brain implant that lets him speak